Best International Stocks To Invest In 2015

Best International Stocks To Invest In 2015: Nu Skin Enterprises Inc.(NUS)

Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements worldwide. The company sells its personal care products under the Nu Skin brand; and nutritional supplements under the Pharmanex brand. Its personal care product line includes core systems, targeted treatments, total care, cosmetic, and Epoch, a product formulated with botanical ingredients. The company?s nutritional supplements product line comprises micronutrient supplements, targeted solution supplements, and weight management products. It also sells Vitameal, which are nutritious meal products for starving children or purchased for personal food storage. In addition, the company offers other products and services consisting of digital content storage, water purifiers, and other household products. It sells its products primarily through a network of independent distributors in north Asia, the Americas, Greater China, Europe, and the south Asia/Pacific. The c ompany also operates retail stores to sell its products in China. As of December 31, 2010, Nu Skin Enterprises operated 40 stores throughout China. The company was founded in 1984 and is headquartered in Provo, Utah.

Advisors' Opinion:

• [By Ben Levisohn]

  Over the past several weeks, [Nu Skin Enterprises (NUS)], a major publicly-traded multilevel marketing (MLM) competitor to Herbalife, began its long-awaited introduction of a new weight management product line to its distributors, located primarily in Asia and the U.S. As a follow up, we conducted discussions with many of our senior-level distributor contacts in the Herbalife organization located in these regions to determine the potential impact on Herbalifes own weight management (i.e., Formula 1 shakes) sales. Based on our feedback, we believe Herbalifes sales momentum has not skipped a beat, with almost all the distributors we spoke with indicating there was n! ot even a slight deceleration in their business since the Nu Skin TR90 product launch.

• [By Jeremy Bowman]

  What: Shares of Nu Skin Enterprises (NYSE: NUS  ) were looking refreshed today, gaining as much as 14% today after the company lifted its guidance significantly for the current quarter and full year.

• [By Ben Levisohn]

  Nu Skin Enterprises (NUS) got clobbered in January when China said it would investigate the multi-level seller’s sales practices in the world’s second-largest economy. Anyone hoping the investigation would be a short-term impediment to Nu Skin found out otherwise today when it released financial results today.

  Nu Skin has plunged 12% to $73.59 at 2:55 p.m., far more than Herblife(HLF), which has dropped 1.9% to $65.37, andUsana Health Sciences(USNA), which has fallen 1.5% to $72.11.

  Reuters

  The Wall Street Journal has the details on Nu Skins results:

  …Nu Skin reported a fourth-quarter profit of $125.3 million, or $2.02, a share, up from $59.2 million, or 97 cents a share, a year earlier. Revenue surged 82% to $1.06 billion. Analysts polled by Thomson Reuters expected per-share profit of $1.99 and revenue of $1.07 billion…

  For the current quarter, the company forecast per-share earnings of 90 cents to 94 cents on revenue of $650 million to $670 million. Analysts polled by Thomson Reuters expected per-share profit of $1.20 and revenue of $732 million.

  Wedbush’s Rommel Dionisio and Alicia Reese slashed their Nu Skin target price to $105 from $143 but think the selloff has created a buying opportunity:

  Until we see greater clarity from a regulatory resolution in China, which initial reports indicate may not be all that severe, but whose timing is uncertain, we prefer to take a more cautious outlook for this important market, and are thus reducing our 2014 EPS estimate to $6.40 from $7.46. A resolution to the Chinese government inquiry, especially a swif! t one, co! uld possibly act as a positive catalyst for shares of NUS.

  With strong core fundamental momentum offset by near term uncertainty regarding China, we believe shares of NUS should trade in line with the peer group average (we previously assumed a 20% premium). On our lowered forecasts, a peer group average EV/2014E EBITDA m

• [By Jayson Derrick]

  Shares of Nu Skin (NYSE: NUS) were halted for the fourth time mid-Thursday afternoon after plunging more than 30 percent; yesterday, shares fell 16 percent.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/best-international-stocks-to-invest-in-2015-3.html